Ignite Creation Date:
2025-12-24 @ 2:28 PM
Ignite Modification Date:
2025-12-26 @ 11:38 PM
Study NCT ID:
NCT01557959
Status:
COMPLETED
Last Update Posted:
2018-06-29
First Post:
2012-02-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Sponsor:
Wake Forest University Health Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-07
Start Date Type:
ACTUAL
Primary Completion Date:
2011-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-02
Completion Date Type:
ACTUAL
First Submit Date:
2012-02-14
First Submit QC Date:
None
Study First Post Date:
2012-03-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-05-01
Results First Submit QC Date:
None
Results First Post Date:
2013-06-28
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-05-30
Last Update Post Date:
2018-06-29
Last Update Post Date Type:
ACTUAL